 | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
May 24, 2024
Reassessed
Removed
- Draft:Mayur Shetty (talk) removed.
May 23, 2024
Reassessed
- Pharmaceutical industry in China (talk) reassessed. Quality rating changed from Start-Class to B-Class. (rev · t) Importance rating changed from Mid-Class to High-Class. (rev · t)
- Pharmaceutical industry in the United Kingdom (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t) Importance rating changed from Unknown-Class to High-Class. (rev · t)
Assessed
- Depyrogenation (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
May 22, 2024
Reassessed
- Etodesnitazene (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Tomáš Cihlář (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)
Assessed
- Dibucaine number (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
May 21, 2024
Renamed
- Caffeine/ergotamine renamed to Ergotamine/caffeine.
- Draft:Justin English renamed to Justin English.
Reassessed
- Axelopran (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Diosmectite (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Emopamil (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Empagliflozin/linagliptin/metformin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Insulin glulisine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Pegvaliase (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Urapidil (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Assessed
- Creolin (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Ergotamine/caffeine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
May 19, 2024
Renamed
Reassessed
- Idarucizumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Oligodynamic effect (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Assessed
- Federal Food, Drug, and Cosmetic Act of 1938 (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
- Semapimod (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Tarlatamab (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
- Category:Tobacco plantation owners (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Removed
- Draft:Heman Bekele (talk) removed.